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The purpose of this study was to identify clinical characteristics that could predict
the diagnosis in ambulatory patients with abdominal pain. We studied 552 un-
selected ambulatory male patients whose average age was 47 years and whose median
duration of pain was 3 weeks. Potentially serious disease occurred in 21% of the
patients. Single abnormal findings had a low predictive value for serious disease.
However, by using combinations of clinical findings, we could construct and test a
decision rule to identify a group of patients who had a low prevalence of serious dis-
ease. This &dquo;low risk&dquo; group contained 36% of all patients with abdominal pain. Lab-
oratory tests were almost always normal in these patients.
Our findings suggest a diagnostic strategy for evaluating abdominal pain: When
the initial examination shows that there is little chance of serious disease, laboratory
tests should be deferred or omitted altogether. In patients who have a very low likeli-
hood of potentially serious disease, it may be useful to regard &dquo;nonspecific abdomi-
nal pain&dquo; as a positive diagnosis, rather than a diagnosis of exclusion.
Introduction
Abdominal pain is an important diagnostic problem because it is common
and has potentially serious consequences. Published clinical descriptions
[1-4] and cost-effectiveness analyses [5] of abdominal pain have been based
on patients who have been hospitalized or seen in emergency rooms for
acute pain. The conclusions of these studies may not apply to office patients
who may differ significantly in the duration of pain and frequency of seri-
ous disease. In order to estimate the cost-effectiveness of diagnostic proce-
dures in office practice, the clinician needs to know disease frequency and
the predictive value of clinical findings in ambulatory patients.
*From the Departments of Internal, Family, and Community Medicine, Dartmouth Medi-
cal School, Veterans Administration Center, Hanover, New Hampshire, and the Department
of Medicine, Stanford University School of Medicine, Veterans Administration Medical Cen-
ter, Palo Alto, California. Address requests for reprints to Dr. Wasson at Dartmouth Medical
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In this report, we present prospective clinical observations of abdominal
pain in unselected ambulatory male patients from several clinics. The fre-
quency of diagnoses and predictive value of findings in the history and phy-
sical examination are described. Certain highly predictive findings were
used in a linear discriminant decision rule for identifying patients with a low
likelihood of serious disease. Since laboratory tests are a major component
of health care costs, we also evaluated the role of these tests in the evalua-
tion of ambulatory patients with abdominal pain. We found that the value
of laboratory tests was negligible in patients with a low likelihood of serious
disease.
Methods
1. DATA ACQUISITION. Clinical information was obtained from self-
referred consecutive male patients with abdominal pain who were seen in
one of three outpatient clinics. The results of a standardized history and
physical examination were recorded on a checklist form. Twenty-three per-
cent of the patients were seen by specially trained medical students, 58%
were evaluated by experienced physician assistants or nurse practitioners,
and the remaining patients were seen only by an internist. All patients seen
by medical students were also seen by an internist, and all patients seen by a
nurse practitioner or physician assistant were seen in consultation by an
internist. The medical records of all patients were reviewed at least 3 months
after the index visit to identify tests and procedures done at the index visit,
as well as subsequent hospitalization and recorded final diagnosis.
The clinical status of the patients was ascertained periodically by mailed
questionnaire (61%) or telephone interview (23%) until the evaluation of
their pain had been completed and a final diagnosis had been ascertained.
In the remaining 16% of patients, the only outcome information available
was the results of a followup visit, in the medical record. The median dura-
tion of followup was 3.9 months, with 8% of the final interviews occurring
within one month of the index encounter. We were able to complete follow-
up in 95% of patients at a rural VA hospital (n=287), 84% of patients at an
urban VA hospital (n = 210), and 98 % of patients at a prepaid group prac-
tice (n=55).
2. ASSIGNMENT OF FINAL DIAGNOSES. An internist (JW) reviewed the
entire medical record for all patients. A specific final diagnosis was made
only if both the history and physical examination data were compatible with
the specific diagnosis, and there were laboratory, radiographic or histologic
data substantiating the diagnosis. For example, the diagnosis of peptic ulcer
disease required a documented ulcer crater on x-ray or gastroscopy. Criteria
for diagnosis and classification of abnormal test or radiograph results are
available on request.
Undocumented causes of abdominal pain were categorized as non-
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specific abdominal pain (NSAP). Some patients with NSAP had actually
been assigned diagnoses of dyspepsia (40%), gastroenteritis (6%), or irri-
table bowel syndrome (4%) by the clinician who cared for the patient.
3. DESIGN OF A DECISION RULE. Differences in patient characteristics
may be used to predict diagnoses or the outcome of illness. In order to clas-
sify patients into prognostic and diagnostic categories based on these
patient characteristics, a decision rule was developed. The rule was designed
to identify patients at low likelihood of having serious disease.
To evaluate without bias the performance of the decision rule, we used
two-thirds of the patients, selected at random (&dquo;original group&dquo;), to develop
the rule, and then used the rule to classify the remaining patients (&dquo;test
group&dquo;). Standard normal theory linear discriminant analysis [6] was used
on the original group to determine which patient characteristics would best
distinguish patients with low likelihood of serious disease. The decision rule
was then used to classify the test group patients. The performance of the
rule in identifying low-likelihood patients among the test group as com-
pared to the original group is a measure of the rule’s reliability.
Results
CHARACTERISTICS OF PATIENTS. We studied 552 male patients with
abdominal pain, of whom all but 10% were VA clinic patients. The mean
age of the patients was 47 years. Many of them (37%) had pain that had
begun within one week of the index visit. Overall, the median duration of
pain was 3 weeks. Only 114 patients (21%) had identifiable disease as the
cause of their pain (Table 1); the percentage of identifiable disease was simi-
lar in all clinics. Peptic ulcer was the most frequent specific diagnosis. Dis-
eases commonly cited as causes of an &dquo;acute abdomen&dquo; occurred infre-
quently : There were only 8 patients with symptomatic cholelithiasis, 4 with
appendicitis, and 3 with bowel obstruction. In the remaining 438 patients,
there was no evidence for a specific diagnosis. These patients are hereafter
referred to as having &dquo;nonspecific abdominal pain.&dquo; Specific diagnoses
occurred more often in older patients (31 % of patients over 60) than in
younger patients (10% of patients under age 40).
Although many patients required hospitalization and surgery, the
majority were managed as outpatients. Patients with specific disease were
hospitalized within one week of the index visit much more often (32% of the
114 patients) than patients with nonspecific abdominal pain (4.6% of the
438 patients). Likewise, surgery was performed in 15% of patients with spe-
cific diagnoses but in only 5 (1.2%) patients with nonspecific pain. Specific
diagnoses were usually discovered promptly: 81% of the patients with speci-
fic diagnoses were identified within one week of the index visit and only 3
patients required longer than three months. One of these patients proved to
have cancer which was discovered only after 2 laparotomies, and the other
two patients had peptic ulcer disease.
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Table 1. Final Diagnoses Established as Causes of Abdominal Pain in
Ambulatory Males
&dquo;Urinary tract infection (2), malabsorbtion (2), bleeding renal cyst (2), urachal cyst, giardiasis,
osteomyelitis of pubis, bleeding rectal polyp, radiation-induced proctitis, inflammatory mass
of pancreas, one patient with alcohol-induced acute hepatitis and pancreatitis.
PREDICTIVE VALUE OF ABNORMAL CLINICAL FINDINGS. A number of find-
ings have been shown to have relatively high sensitivity for specific diseases
causing abdominal pain. For example, 65% of patients with acute appendi-
citis have right lower quadrant tenderness [1]. Twenty-four of our patients
had right lower quadrant tenderness: 2 had appendicitis and 22 had other
diagnoses. Thus, only 8% of our patients with right lower quadrant tender-
ness had appendicitis. The low predictive value of this finding is a direct
consequence of the very low frequency of appendicitis in this unselected
group of patients. Likewise, only 5 Vo of patients with right upper quadrant
tenderness had acute symptomatic cholelithiasis. No findings accurately
predicted specific disease in these ambulatory patients.
A DECISION RULE THAT IDENTIFIES AMBULATORY MALE PATIENTS WITH
NONSPECIFIC ABDOMINAL PAIN. Although no single finding in the history
and physical examination differentiates between specific diagnoses and
NSAP, combinations of clinical characteristics did discriminate effectively.
Linear discriminant analysis identified clinical findings which were indepen-
dent and significant predictors. These were combined into a decision rule to
discriminate between specific diagnoses and NSAP (Table 2). The value of
each finding for discriminating between NSAP and specific diagnoses is
expressed in a coefficient calculated by the linear disciminant process. Each
coefficient may be regarded as a &dquo;point score&dquo; for the finding. To use the
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Table 2. A Decision Rule for Ambulatory Males with Abdominal Pain
Rule: Total score less than zero means a low likelihood of serious disease.
rule, the appropnate point score is given for each finding that is present; no
point score is given for absent findings.
Table 3 summarizes the performance of the decision rule, which was
created on a random sample of 370 patients and prospectively tested on the
remaining 182 patients. The rule classified the test group identically to the
original group. Ninety-four percent of the test patients with negative
abdominal pain scores had NSAP. The rule correctly identified 44040 of 144
test patients with NSAP as being at low risk of serious illness. Of the 29
patients in the test group with specific diagnoses other than peptic ulcer dis-
ease, 28 were correctly identified as at relatively high risk of serious illness;
1 patient was misclassified.
We could not distinguish between peptic ulcer disease and NSAP by
linear disciminant analysis (Table 3). Thus, of the 4 test patients with speci-
fic diagnoses that were misclassified by the decision rule, 3 had peptic ulcer
disease.
USE oF LABORATORY TESTS. Laboratory tests were used extensively,
although no tests were specified as part of the study protocol. The most fre-
quently used tests were hemoglobin determination (in 53% of patients),
white blood count (in 53%), urinalysis (in 34%), serum chemistry panel (in
32070), and serum amylase ( in 14%). Overall, an average of 2.0 of these tests
were obtained on each patient at the index visit. The frequencies of test use
and abnormal test results are shown in Table 4. Patients with a negative
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Table 3. Performance of the Decision Rule for Identifying Nonspecific Abdominal Pain
in Ambulatory Males 
__
- - -- --- --- - -
&dquo;None of the differences between rule performance on &dquo;onginal&dquo; and &dquo;teet&dquo; patients is significant.
abdominal pain score (low risk patients) had 1.4 tests obtained at the index
encounter, of which 3% were abnormal.
Discussion
The findings in this study differ from previous reports of patients with
abdominal pain in one crucial respect: the frequency of specific disease is
much lower. A low frequency of specific disease means that the predictive
accuracy of tests will also be low. In our unselected, ambulatory patients,
the frequency of specific disease was 23% when pain had lasted less than a
week and 19% when pain had lasted more than a week. Previous studies of
hospitalized or emergency room patients have reported a specific disease
frequency of 50% or more [1,2,3]. The difference is undoubtedly due to
selection of patients for hospitalization or special study on the basis of find-
ings suggestive of specific disease. The differences in specific disease fre-
quency are important if one is trying to predict the yield of laboratory tests
and formulate guidelines for optimal use of tests. The high frequency of
nonspecific disease in unselected patients makes it difficult to identify speci-
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Table 4. Use and Results of &dquo;Routine&dquo;’ Laboratory Tests in Ambulatory Males
with Abdominal Pain
°Hemoglobin or hematocrit, white blood count, urinalysis, serum chemistry panel, serum
amylase.
fic disease efficiently. Proving specific disease usually means showing that a
patient has one or more of its cardinal manifestations. This study and
others [1, 4] have shown that abnormal history data, physical examination
findings, and laboratory tests occur often in abdominal pain patients who
do not have specific disease. If specific disease frequency is low, the number
of these misleading false-positive findings may exceed the number of true-
positive results. If false-positive results greatly outnumber true-positive
results, the predictive accuracy of tests will be low, and they will contribute
relatively little to making a diagnosis of specific disease.
In this report, we describe a solution to the problem of the low predictive
accuracy of tests for patients in whom the prevalence of specific disease is
low. We partition the patients into two groups, one with a high risk of seri-
ous disease and one with a low risk. In the low risk group, laboratory tests
are likely to be futile because the predictive value of a positive test will be
very low. In the high risk group, the probability of an abnormal test result
being true positive will be significantly increased as compared to that for
low risk patients, although false-positive results may still outnumber true-
positive results. We have described a decision rule for assigning an abdomi-
nal pain patient into a group with either a high risk of specific disease or a
low risk. Over one-third of our patients were defined as &dquo;low risk&dquo; by the
rule, and only 10 of 186 low risk patients had specific disease. In these &dquo;low
risk&dquo; patients, the probability of disease will be low even if there is a positive
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test result. For example, if the prevalence of a specific disease (e.g., pan-
creatitis) in low risk patients is 0.001 (we observed 0/186) and the true- and
false-positive ratios of a test (e.g., serum amylase determination) for the
disease are 0.8 and 0.05 respectively, there will be approximately one true-
positive result and 50 false-positive results if the test is obtained on 1,000
&dquo;low risk&dquo; patients. The probability of specific disease in the case of a posi-
tive result will be 0.02. Since false-positive results will far outnumber true-
positive results in low risk patients, watchful waiting and empirical therapy,
rather than diagnostic testing, will usually be the appropriate initial man-
agement strategy. The decision rule that we have described will identify
abdominal pain patients for whom diagnostic testing is a low-yield strategy.
Our findings have several limitations. First, some &dquo;low risk&dquo; patients
with nonspecific abdominal pain (NSAP) may have syndromes that will
benefit from specific therapy. The decision rule is not designed to subclas-
sify low risk patients into separate, potentially treatable syndromes. For
example, some low risk patients have the irritable bowel syndrome or dys-
pepsia. The clinician who has classified a patient as being at low risk for
serious illness should still try to make a syndrome diagnosis. The purpose of
the decision rule is to reassure the clinician that laboratory tests are unlikely
to be useful, not to bring the clinical evaluation to a possibly premature
conclusion.
Second, the decision rule places patients who had proven peptic ulcer dis-
ease into both the &dquo;high-&dquo; and &dquo;low&dquo; risk groups. If indicated, evidence for
peptic ulcer disease should be sought in both &dquo;high risk&dquo; and &dquo;low risk&dquo;
patients. We have described the problems of identifying peptic ulcer disease
in ambulatory patients [7].
Third, the decision rule was based on a male population in prepaid
ambulatory clinics and may have limited application to other patient popu-
lations. Although the rule performed well in prospective testing, it is not
designed to identify diseases of women and may not be applicable to other
male populations. The decision rule should be used with caution until it has
been tested in other populations. In addition, the strategy of partitioning
patients into high- and low risk subgroups is less advantageous when speci-
fic disease prevalence is higher than in our patient population.
Fourth, the rule is intended to be used in conjunction with a common-
sense interpretation of other indicators of serious disease. Neither common
indicators of rare diseases nor rare indicators of common diseases appear in
the decision rule. Linear discriminant analysis, which was used to create the
rule, identifies the findings which best contribute to optimum discrimina-
tion between two groups. Findings that occur very infrequently are usually
not identified as useful by linear discriminant analysis. There were very few
gravely ill patients in this study, and therefore clinical indicators of shock,
for example, do not appear in the rule. The decision rule is meant to triage
patients who have not already been identified as seriously ill by abnormal
vital signs or clinical appearance.
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Fifth, some patients who were felt to have nonspecific abdominal pain
may have in fact had serious disease that became evident only after the last
followup interview. This uncertainty is inevitable in unselected self-referred
patients, because it is not possible to subject each patient to a series of pro-
cedures that would completely exclude serious disease. The experienced
clinician knows that there are many abdominal pain patients in whom
exhaustive testing is inconclusive and periodic re-evaluation over many
months is the only way to reach diagnostic certainty. Reasoning that serious
disease eventually becomes recognizable to a competent physician, we used
three-month followup interviews and examinations to insure against miss-
ing serious disease. All but three patients with specific diagnoses had their
diagnoses established within three months of the index visit, and 8107o were
diagnosed correctly within one week of the index visit. Of the 438 patients
with NSAP, 61 ~7o reported that their pain was improved or gone at the time
of the last followup and that no specific diagnosis had been established.
Although some patients with persistent NSAP might eventually be proven
to have a specific diagnosis, we could find no evidence for diagnosable dis-
ease in the medical records of these patients. Nevertheless, despite this fol-
lowup protocol, there remains some uncertainty about what happened to
these patients after the final followup interview. Therefore, the clinician
should remember that the abdominal pain decision rule is intended for use
at the initial encounter. Its purpose is to identify patients in whom diagnos-
tic testing is not likely to be useful. It should be used as part of a compre-
hensive diagnostic strategy that includes followup care and re-evaluation
for those whose pain remains a concern to them or their physician.
We have proposed a diagnostic strategy which considers nonspecific
abdominal pain as a positive diagnosis rather than as a diagnosis of exclu-
sion. Carefully applied, this strategy should be safe and more economical
than the time-honored method of first excluding serious disease before
deciding that an illness is nonspecific. The decision rule reduces but does
not eliminate uncertainty. Therefore, clinicians should use it with the same
caution as other types of diagnostic information, being alert for the excep-
tional patient and using the subsequent clinical course as additional diag-
nostic information.
Acknowledgments
The clinicians of the White River Junction and Palo Alto Veterans Administration
Medical Centers and the Kaiser Foundation Hospital of Santa Clara made an essen-
tial contribution to this study. Special appreciation is extended to Kenneth Wein-
berg, M.D., Janice McLain, M.D., and Charles Shapiro, M.D. Alice Rockwell and
Catherine Gaudette prepared the manuscript. Thomas Almy, M.D., provided valua-
ble advice. Theodore Colton, Ph.D., Lincoln Moses, Ph.D., and Byron Brown, Jr.,
Ph.D., were statistical consultants.
 at PENNSYLVANIA STATE UNIV on October 5, 2016mdm.sagepub.comDownloaded from 
224
References
1. Staniland JR, Ditchburn J, de Dombal FT: Clinical problems. Clinical presenta-
tion of acute abdomen. Study of 600 patients. Br Med J 3: 393-398, 1972
2. de Dombal FT, Leaper DJ, Horrocks JF, et al.: Human and computer-aided
diagnosis of abdominal pain. Further report emphasis on performance of clini-
cians. Br Med J 1:376, 1974
3. Wilson DH, Wilson PD, Walmsley RG, Horrocks JC, de Dombal FT: Diagnosis
of acute abdominal pain in the accident and emergency department. Br J Surg
64:250-254, 1977
4. Brewer RJ, Golden GT, Hitch DC, Rudolf LE, Wangensteen SL: Abdominal
pain. An analysis of 1,000 consecutive patients. Am J Surg 131:219-223, 1976
5. Neutra R: Indications for the surgical treatment of suspected acute appendicitis.
A cost-effectiveness approach. In, Bunker JM: Costs, risks, and benefits of sur-
gery. New York, Oxford University Press, 1977
6. Lachenbruch P: Discriminant analysis. New York, Hofner Press, 1975
7. Marton KI, Sox HC, Wasson JH, Duisenberg CE: The clinical value of the
upper gastrointestinal tract roentgenogram series. Arch Intern Med 140:191-195,
1980
 at PENNSYLVANIA STATE UNIV on October 5, 2016mdm.sagepub.comDownloaded from 
